SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Express Scripts Holding

22

Express Scripts Holding

ESRX

Over the past decade, Express Scripts has become the largest pharmacy benefit manager in the U.S. as the industry has consolidated. The company processes more than 1.5 billion claims every year. The question now is if it can compete using its unique stand-alone business model with rivals like CVS Health that pursue a multi-pronged approach. Express Scripts has benefited from the wave of newly insured patients as a result of the Affordable Care Act and has significantly expanded its profit margins over the past six years. The company’s simmering contract dispute with insurance giant Anthem, its largest customer and 18% of its revenue, was an undercurrent to 2016; the companies severed ties in April 2017, sending Express Scripts’ stock plummeting. The move leaves the company to find a way forward as it still covers 65 million people and processes about 1 billion prescriptions a year.

Looking for leads, investment insights, or competitive intelligence?

CEO

Timothy C. Wentworth

CEO Title

President, Chief Executive Officer & Director

Sector

Health Care

Industry

Health Care: Pharmacy and Other Services

HQ Location

St. Louis, MO

Years on Fortune 500 List

18

Employees

25,600

Profile provided by S&P Global.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$100,288-1.4%
Profits ($M)$3,404.437.5%
Assets ($M)$51,745
Total Stockholder Equity ($M)$16,236
Market Value — as of March 31, 2017 ($M)$39,567
Profit Ratios
Profit as % of Revenues3.4%
Profits as % of Assets6.6%
Profits as % of Stockholder Equity21.0%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.39
EPS % Change (from 2015)51.4%
EPS % Change (5 year annual rate)16.3%
EPS % Change (10 year annual rate)20.5%
Total Return
Total Return to Investors (2016)-21.3%
Total Return to Investors (5 year, annualized)9.0%
Total Return to Investors (10 year, annualized)14.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Express Scripts Holding

Tech's Next Big Wave: Big Data Meets Biology

Just about everyone agrees that America's health care system is broken. Is better data—and the ability to harness it—the medicine we've been looking for?

Read More →
Cigna Is Buying Express Scripts in a $54 Billion Health Industry Deal

Another move toward consolidation between insurers and the companies that oversee drug benefits.

Read More →
Amazon, Berkshire Hathaway and J.P. Morgan Are Forming a Non-Profit Health Care Venture

Sparking a selloff in the shares of a host of health care-related companies.

Read More →
Express Scripts Shares Flop Over 11% on Likely Loss of Its Biggest Customer

Anthem had sued Express Scripts in March last year, accusing it of charging too much for drugs.

Read More →